DAPACONIC 10MG 15

About

Dapagliflozin is an oral antidiabetic agent belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by selectively inhibiting SGLT2 in the renal tubules, which is responsible for the reabsorption of glucose from the filtered blood back into the bloodstream. By blocking this transporter, dapagliflozin significantly reduces glucose reabsorption and increases the excretion of glucose in the urine, leading to a reduction in blood glucose levels. This mechanism is independent of insulin secretion or action, making it effective even in patients with impaired insulin production.

Beyond its primary role in glycemic control, dapagliflozin has demonstrated substantial benefits in reducing the risk of cardiovascular death and hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors. Furthermore, it provides significant renal protection, reducing the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with chronic kidney disease. Its action also contributes to modest weight loss and blood pressure reduction, offering a comprehensive approach to managing diabetes and its associated comorbidities.

Uses

• Treatment of type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.
• To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease.
• As an adjunct to diet and exercise.

Directions For Use

Take this medication orally, usually once daily in the morning, with or without food, as directed by your physician. Swallow the tablet whole.

Benefits

• Effectively lowers blood glucose levels.
• Reduces risk of major adverse cardiovascular events.
• Provides significant renal protection.
• Contributes to modest weight reduction.
• Helps lower blood pressure.
• Insulin-independent mechanism of action.

Side Effects

• Genital yeast infections
• Urinary tract infections (UTIs)
• Increased urination
• Thirst
• Dizziness
• Hypotension (low blood pressure)
• Ketoacidosis (rare but serious)
• Kidney problems (worsening)
• Back pain
• Nausea
• Flu-like symptoms
• Rash

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of ketoacidosis and hypoglycemia, especially when combined with dapagliflozin.
• Pregnancy - Not recommended during the second and third trimesters of pregnancy due to potential adverse effects on fetal kidney development. Consult a doctor.
• Breastfeeding - Avoid use during breastfeeding as it is unknown if dapagliflozin is excreted in human milk and could pose risks to the infant.
• Liver - Generally safe for use in mild to moderate liver impairment; however, caution is advised, and monitoring may be necessary in severe cases.
• Kidney - Use with caution and dose adjustment may be required in patients with impaired renal function. Not recommended for severe renal impairment or dialysis.
• Lung - No specific contraindications or major concerns related to lung conditions; however, general patient health should always be considered.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.